Vitro and PhosphoSolutions Collaborate to Study Stem Cell Proteomics
News Jan 16, 2006
Vitro Diagnostics, Inc. dba Vitro Biopharma has announced establishment of research collaboration with PhosphoSolutions, LLC (Aurora Colorado) to characterize intracellular signaling mechanisms involved with regulation of stem cell growth and differentiation.
Vitro has previously developed 29 adult pancreatic stem cell lines and has developed methodologies to induce differentiation of functional human beta cells from these cell lines.
While phosphoproteins represent only 15-20% of all proteins, they regulate virtually every cellular function, including growth and differentiation. These phospho-specific antibodies can thus be used to assess the activity of a protein, not simply its level of expression.
"We are pleased to be working with Vitro to apply our expertise and antibodies to study intracellular signaling pathways involved in the growth and differentiation of Vitro's stem cells," said Dr. Ron Lickteig, Ph.D., senior scientist at PhosphoSolutions.
Stem cells exhibit immortality through self-renewal properties that are typically activated in normal development.
Early investigations by Vitro and PhosphoSolutions have provided evidence suggesting interaction between these key regulatory pathways through phosphorylation of a well-known protein, (GSK3-b(Beta)), supporting work recently completed by other researchers.
The goals of the collaboration are to further investigate intracellular signaling mechanisms underlying stem cell self-renewal and those pathways involved with differentiation of stem cells into functional cells, including beta cells that synthesize and release insulin.
Computation and Chemistry Combine to Create World-First Auxetic ProteinNews
A team of chemists at the University of California, San Diego (UCSD) has now designed a two-dimensional protein crystal that toggles between states of varying porosity and density. This is a first in biomolecular design that combined experimental studies with computation done on supercomputers. The research, published in April 2018 in Nature Chemistry, could help create new materials for renewable energy, medicine, water purification, and more.
Fructose Formula Poses Risk to Babies With Metabolic DisorderNews
Babies with inherited intolerance of fructose face a risk of acute liver failure if they are fed certain widely available formulas containing fructose, pediatricians and geneticists are warning. Baby formula manufacturers should remove fructose or sucrose, or explicitly label their products to allow parents to avoid those sweeteners if necessary, the doctors say.